Single-use bioreactors are gaining popularity as they minimize the risks of cross-contamination and product mix-ups. They offer benefits such as lower capital costs, reduced validation requirements, improved production flexibility, ease of scale-up, and disposability. Single-use bioreactors help produce biologics such as monoclonal antibodies, vaccines, and recombinant proteins more...